How Wegovy and Mounjaro Dosing Schedules Compare
Understanding Wegovy Dose vs Mounjaro Dose Progression Pathways
The fundamental difference between Wegovy dose vs Mounjaro dose lies in their escalation timelines and target maintenance levels. Wegovy follows a 16-week escalation from 0.25mg to 2.4mg maintenance, with each dose taken for 4 weeks before progression. Mounjaro uses a different approach, starting at 2.5mg and potentially escalating to 15mg based on tolerability and response. Both medications require gradual dose increases to minimise gastrointestinal side effects, but their pathways differ significantly.
At EverydayMeds, we stock every dose in both progression schedules, eliminating the common problem of patients having to switch pharmacies mid-treatment. Our comprehensive inventory means whether you're on week 1 of Wegovy or approaching Mounjaro maintenance doses, you'll receive consistent supply and support. This continuity proves crucial for treatment adherence, as changing suppliers can cause dangerous interruptions in your medication schedule.
Wegovy vs Mounjaro Pricing Structure and Dose Economics
When comparing Wegovy dose vs Mounjaro dose costs, pricing varies significantly across the escalation schedule. Wegovy starts at £79.99 for 0.25mg (weeks 1-4), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for 2.4mg maintenance doses. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to access these prices. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) cost £169.99, providing your first 8 weeks of treatment in one order.
Mounjaro follows its own pricing structure aligned with higher mg strengths, reflecting the different active pharmaceutical ingredient and manufacturing process. Both medications represent significant monthly investments at maintenance doses, but our bundle options provide supply security without the stress of monthly reordering. The Ultimate Stability Trio (three 2.4mg Wegovy pens) costs £649.99, securing three months of maintenance treatment once you reach the final dose escalation.
Clinical Evidence Behind Wegovy Dose vs Mounjaro Dose Selection
The STEP clinical trials demonstrated that Wegovy's 2.4mg maintenance dose, when used alongside a reduced-calorie diet and increased physical activity, supported an average weight reduction of approximately 15% over 68 weeks (Wilding et al., NEJM, 2021). This evidence informed the MHRA's licensing of the specific dose escalation schedule, ensuring optimal balance between efficacy and tolerability.
Mounjaro's clinical programme used different trial designs and patient populations, making direct comparison of percentage weight reductions inappropriate. Both medications underwent rigorous testing to establish their respective optimal dosing schedules, and both are subject to MHRA additional monitoring with Black Triangle status, reflecting their relatively recent market introduction.
How Wegovy's GLP-1 Mechanism Influences Dose Requirements
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for blood sugar regulation and appetite control. The medication works primarily in your brain's appetite centres, reducing food cravings and promoting earlier satiety after meals. This mechanism requires the gradual dose escalation from 0.25mg to 2.4mg because your GLP-1 receptors need time to adjust to increased stimulation. Starting at full dose would likely cause severe nausea, vomiting, and other gastrointestinal effects that could force treatment discontinuation. The 4-week intervals between dose increases allow your digestive system to adapt while maintaining therapeutic benefit.
EverydayMeds Ordering Process for Complete Dose Range
Our streamlined process begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. A qualified prescriber reviews your assessment within 3 working days (or 24 hours with express service), determining both medication choice and appropriate starting dose. Once approved, we dispatch your medication via next-day delivery using temperature-controlled packaging to maintain the cold chain integrity essential for both Wegovy and Mounjaro. Our GPhC-registered pharmacy (#9012878) ensures every step meets regulatory standards for prescription-only medicine supply. You'll receive SMS tracking updates and storage instructions with each delivery.
Storage and Practical Considerations in Wegovy vs Mounjaro Dose Management
Both medications require refrigeration at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability versus Mounjaro's 21 days. This advantage proves significant for business travellers or holiday periods where refrigeration isn't assured. Wegovy uses Novo Nordisk's FlexTouch pen system, pre-filled with exact doses and featuring clear dose escalation markings. Each pen delivers 4 weekly injections, with dose progression requiring a new pen strength rather than dial adjustments. The injection process remains identical across all dose levels, reducing complexity as you progress through the escalation schedule.
Why Complete Dose Availability Matters for Wegovy vs Mounjaro Treatment Success
Treatment interruptions due to dose unavailability can trigger withdrawal effects and rapid weight regain, with STEP trial extensions showing patients regained approximately two-thirds of lost weight within one year of stopping Wegovy. Having every dose immediately available prevents these dangerous gaps that occur when pharmacies stock only popular strengths. Many patients abandon treatment entirely after experiencing supply disruptions, particularly during the transition from starter doses to maintenance levels.
Our comprehensive inventory eliminates this risk, supporting long-term treatment adherence essential for sustained weight management. Whether you need to repeat a dose due to tolerability issues, progress ahead of schedule, or maintain treatment during supply shortages affecting other pharmacies, EverydayMeds ensures uninterrupted access. This reliability proves crucial given that weight management represents a long-term commitment rather than short-term intervention.
Making Your Wegovy vs Mounjaro Dose Decision with Expert Support
Both Wegovy and Mounjaro are available from EverydayMeds, with our prescribers helping determine which medication and dosing approach suits your individual circumstances. Factors influencing this decision include your previous experience with GLP-1 medications, concurrent health conditions, injection preferences, and lifestyle considerations like travel frequency. Our clinical team considers these elements during assessment, ensuring you start with the most appropriate option rather than trial-and-error switching. You can begin your assessment today using discount codes FIRST40 (new customers) or DOSE25 (returning customers) applied at checkout, with complete dose progression support available at https://everydaymeds.co.uk/collections/wegovy throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
